AIM ImmunoTech Inc. — Director's Dealing 2012

May 21, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2012-05-17

Reporting Person: STRAYER DAVID R (Medical Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-05-17	Common Stock	P	5100	$0.255	Acquired	236032	Direct
2012-05-18	Common Stock	P	44900	$0.255	Acquired	280932	Direct